Core Viewpoint - JD Property Development Co., Ltd. (referred to as "JD Property") has resumed its IPO process in Hong Kong after nearly three years, following the listing of JD Industrial in December 2025 [1][3]. Group 1: Company Overview - JD Property focuses on the development and management of modern logistics infrastructure, leveraging its capabilities in project acquisition, financing, asset management, and capital circulation [5]. - The company began its operations in 2007, initially as part of JD Group's logistics strategy, and started independent operations in 2018 [7]. Group 2: Financial Performance - JD Property's revenue for 2023, 2024, and the first nine months of 2025 was reported as 2.868 billion, 3.417 billion, and 2.478 billion RMB respectively, with gross margins of 70.4%, 69.7%, and 67.9% [8][9]. - The company has faced criticism for its high dependency on internal transactions with JD Group, which accounted for over 30% of its revenue from infrastructure solutions [8][11]. Group 3: Business Model and Strategy - JD Property is transitioning towards a light-asset business model, aiming to enhance capital efficiency through systematic capital circulation strategies [12][13]. - The company has established multiple funds and investment tools, managing a total asset scale of 41 billion RMB as of September 30, 2025 [13]. Group 4: Profitability and Losses - Despite revenue growth, JD Property has not achieved profitability, reporting net losses of 1.829 billion, 1.200 billion, and 0.159 billion RMB for the respective periods [14]. - The losses are attributed to fair value losses on investment properties and assets held for sale, amounting to 1.8 billion, 1.6 billion, and 0.9 billion RMB [14]. Group 5: Future Plans - The proceeds from the IPO are intended for expanding the infrastructure asset network in key overseas logistics nodes, building a global talent team, and enhancing the density and quality of its infrastructure assets in China [14].

Group 1 - JD Health has established a medical team for its health checkup centers, with 100% of the doctors holding intermediate or higher titles, and 22% of key department heads being chief physicians [1] - The online service team consists of doctors with senior titles, ensuring a high level of expertise in patient care [1] Group 2 - JD Health is promoting the application of AI technology in its health checkup centers, which has reduced the average waiting time for users by nearly 30 minutes through an intelligent triage system [2] - The AI general inspection system has improved the efficiency of report generation by 135%, leading to a reduction of 3.5 days in the average time for users to receive their health checkup reports [2]

Core Viewpoint - JD Smart Development Co., Ltd. has submitted its prospectus for an IPO, marking it as the seventh company under JD Group to seek public listing, following JD Group, Dada Group, JD Health, JD Logistics, Debang Co., and JD Industry [1][9]. Company Overview - JD Smart Development is a platform enterprise focused on the development, operation, and asset management of modern supply chain infrastructure, aiming to provide integrated supply chain solutions through high-standard logistics parks, industrial parks, and data centers [3]. - The company has established a three-dimensional business model that emphasizes heavy asset development, light asset operation efficiency, and capital cycle empowerment [3]. Business Structure - The company has three main pillars driving its operations: - Infrastructure solutions, which are the main revenue source, contributed 2.564 billion RMB in the first nine months of 2025, accounting for 85.4% of total revenue [5]. - Asset value enhancement focuses on optimizing existing assets, achieving a cumulative asset appreciation of 1.3 billion RMB from 2020 to 2024, with an average return rate of 40% [6]. - Fund and partnership investment platform management promotes a light asset transformation, with a projected management fee income of 197 million RMB in 2024, reflecting a compound growth rate of 30% [6]. Financial Performance - In 2023, the company reported total revenue of 2.9 billion RMB, expected to grow to 3.4 billion RMB in 2024, with a 21.2% increase in revenue for the first nine months of 2025 compared to the same period in 2024 [12]. - The company experienced a net loss of 1.829 billion RMB in 2023, which is projected to decrease to 1.2 billion RMB in 2024, and further to 159 million RMB in the first nine months of 2025 [14]. - Adjusted net profit is expected to grow significantly, with a 77% increase in the first nine months of 2025 compared to the same period in 2024 [12]. Market Context - The IPO submission aligns with the trends in intelligent manufacturing and supply chain infrastructure upgrades, driven by policies like "Made in China 2025" and the "14th Five-Year Plan" [17]. - The demand for high-standard, intelligent infrastructure is increasing globally, providing a broad market space for companies like JD Smart Development [19]. Competitive Landscape - The domestic supply chain infrastructure industry is becoming increasingly competitive, with major players like ProLogis and Wanwei Logistics intensifying their market presence [15]. - JD Smart Development aims to differentiate itself by leveraging JD Group's core supply chain capabilities and focusing on emerging sectors like new energy vehicles and cross-border e-commerce [21].

Core Insights - JD Health's health examination center aims to establish a new professional health management institution, creating a "third pole" in China's health examination sector to break the long-standing "bipolar" pattern between public hospitals and traditional private examination institutions [1][4] Group 1: Professional Assurance - The health examination center has built its own medical team, with 100% of doctors holding intermediate or higher titles, and 22% of key department heads being chief physicians [1][4] - The center utilizes AI technology to significantly enhance service efficiency and accuracy, reducing average waiting times by nearly 30 minutes and increasing report production efficiency by 135%, leading to a 3.5-day reduction in the average time to receive examination reports [5] Group 2: Service Experience - The center is equipped with international top-brand testing equipment and has developed a unique service standard comparable to airline service, enhancing user experience through thoughtful design elements such as heated coupling agents and senior-friendly restroom facilities [5] Group 3: Integrated Health Management - Leveraging JD Health's robust supply chain and diverse medical service resources, the examination center links "medical, testing, diagnosis, and pharmacy" into a one-stop service ecosystem, creating a health management loop of "precise discovery - professional resolution - dynamic tracking" [2][5] - Post-examination, users can seamlessly access top-tier expert resources from JD Internet Hospital for further consultations, and various services like JD Pharmacy and JD Nurse at Home can quickly provide integrated solutions based on users' specific health needs [5] Group 4: Future Developments - The health examination center plans to continue deepening the application of AI technology to enhance professional services and management decision-making efficiency, while also expanding its store network to increase the coverage of the "third pole" service, allowing more users to access high-quality professional health management services [6]

▲京东产发基本情况 1月26日，京东智能产发股份有限公司（下称"京东产发"）正式递交A1招股申请文件，美银证券、高盛 及海通国际担任联席保荐人。 事实上，京东产发的上市筹备早有布局。早在2023年，京东集团便曾披露过分拆京东工业、京东产发到 港股独立上市的计划，并实现两大业务板块专业化运营。同年3月底，京东产发首次向港交所递交上市 申请，但此后上市进程一度中止。直到三年后，其上市才重新被提上日程。 回顾"京东系"的资本布局，此前京东、达达（2025年已私有化退市）、京东健康、京东物流、德邦物 流、京东工业已先后被推向资本市场，形成了覆盖电商、物流、健康、工业等领域的上市矩阵。若京东 产发成功上市，"京东系"将收获第七个IPO。 招股书显示，京东产发是中国领先的现代化基础设施开发及管理平台，聚焦物流园，并在全球持续扩 张。作为京东集团供应链生态系统的基石，凭藉与生俱来的对商流及物流的深刻洞察力，公司拥有整合 业务资源、促进区域经济发展的独特能力。利用在项目获取、融资渠道、资产管理及资本循环方面已被 证明的综合能力，其持有并管理着一个覆盖核心物流节点的庞大资产网络，并加速向轻资产模式转型。 | | | 进学12月 ...

品牌结构呈现"本土崛起、国际集聚"态势。国潮文创、新中式茶饮等本土品牌多点开花，来自20个国家 的国际品牌聚焦时尚消费赛道，通过在地化创新深耕市场。其中，Le Labo全球首家四合院店、迪奥之 家全国首店、格拉夫国内首家双层旗舰店等一批标志性首店集中亮相，增强品牌认同，提升北京国际消 费吸引力。 消费门类分布均衡，业态创新亮点突出。其中，奇梦岛全国首家旗舰店、泡泡马特旗下的珠宝品牌 POPOP北京首店等项目聚焦跨界融合、线上线下联动等新模式，焕发创新活力；在餐饮消费首店领 域，三元食品旗下的"北京市牛奶公司"、京华茶业推出的"京华飘雪"等品牌凸显"本土主导、多元包 容"，场景创新与文化融合成为核心亮点；服务消费首店领域，北京工美集团打造的"予寻京喜"艺术非 遗旗舰店、京东健康推出的首家国医馆"之业堂"等项目以"垂直细分"为特色，在文娱、体育、美丽健康 等领域精准对接个性化需求，激发市场潜能与活力，推动服务消费升级。 北京商报讯（记者 刘卓澜）2025年，北京通过扩大时尚消费、支持商圈商街品质提升、鼓励首店首发 等举措，依托优质商业载体、展会场馆及文化地标等特色资源，北京首发经济实现跨越式发展。1月27 日，北 ...

Investment Rating - The report provides a positive outlook on the food and beverage sector, recommending leading companies in snacks and condiments [7][9]. Core Insights - The report highlights a decline in retail sales growth, with December's year-on-year growth at 0.9%, down 0.4 percentage points from November, indicating a potential slowdown in consumer spending [8]. - The food and beverage sector shows positive signals, particularly for Moutai, which is expected to maintain stable pricing due to supply-side constraints and increasing demand [9][10]. - The report anticipates that service consumption will be the main growth driver for 2026, with an expected overall consumption growth rate of 5.1% [8]. Industry Size - The industry comprises 1,216 stocks, with a total market capitalization of 17,809.1 billion and a circulating market capitalization of 16,466.7 billion [3]. Performance Metrics - The absolute performance over 1 month, 6 months, and 12 months is 4.4%, 7.0%, and 27.3% respectively, while the relative performance is 3.4%, -7.1%, and 4.5% [5]. Sector Recommendations - The report recommends focusing on leading companies in various sectors, including: - Food and beverage: Emphasis on Moutai and other snack brands [9]. - Textile: Anticipation of a turnaround for Li Ning in 2026 [13][14]. - E-commerce: Positive outlook on Alibaba due to its cloud business growth potential [24]. - Agriculture: Continued recommendation of leading pig farming companies and attention to planting policy catalysts [30]. Specific Company Insights - Moutai is expected to see stable pricing and growth in demand, with a focus on core products [9]. - Li Ning is actively launching new products and expanding its retail presence, aiming for a rebound in 2026 [13][14]. - Alibaba's cloud business is projected to accelerate growth driven by AI advancements [24]. - The agricultural sector is advised to focus on leading pig farming companies and the implications of planting policies [30].

Core Viewpoint - The Hong Kong internet healthcare stocks continue to decline, with Ark Health (06086.HK) experiencing the largest drop of 18.75% as of the report date [1] Company Summary - Ark Health plans to conduct a share placement of 45.181 million shares, representing approximately 3.26% of the expanded issued share capital, at a price of HKD 3.32 per share, which is an 11.94% discount to the previous closing price [2] - The total funds raised from this placement are expected to be HKD 150 million, with a net amount of approximately HKD 144 million [2] - Approximately 90% of the funds will be allocated to the development of an AI-driven chronic disease management platform, including algorithm model development, infrastructure expansion, talent acquisition, data collection, and service promotion [4] - The remaining 10% will be used for working capital and general corporate purposes [4] Industry Summary - Ark Health's strong profit forecast for 2025 indicates expected revenue of RMB 3.5 to 3.55 billion, representing a year-on-year growth of about 30%, with net profit projected between RMB 7 million and 10 million [8] - The growth in 2025 is attributed to the integration of the "familiar doctor-patient relationship" model with AI technology, enhancing platform attractiveness and expanding the consumer base [8] - The Chinese internet healthcare market is projected to grow significantly, with the market size increasing from RMB 43.6 billion in 2016 to RMB 435.1 billion in 2024, reflecting a compound annual growth rate of 33.32% [9] - The demand for convenient medical services is driven by an aging population and chronic disease patients, alongside the uneven distribution of medical resources, which forms the underlying motivation for industry growth [8]

走到室外，开启运动模式；长时间伏案工作，腕间振动，提醒活动一下；清晨起床，显示睡眠情 况……智能手表正成为数以亿计用户的健康管理好帮手。 业内人士表示，随着人工智能（AI）大模型、多模态传感器、大数据技术与健康产业的深度融 合，包含智能手表在内的智能健康设备正让健康管理从"偶尔检查"变为"长期追踪"。 近年来，政策红利持续释放。2025年4月，商务部、国家卫生健康委等12部门联合印发的《促进健 康消费专项行动方案》明确提出，"强化科技赋能和智能应用，推出小体积、便携式智能健身和户外运 动装备器材"，"重点支持可穿戴运动电子产品与运动器械发展与迭代"。这一政策导向，直接激发了产 业链上下游的创新活力，推动产品加速从实验室走向消费市场。 同时，居民日益增长的健康需求，为市场增长提供了坚实基础。2026年元旦假期，消费电子市 场"手机+智能手表/手环"套购订单增速明显，这种通过设备间深度绑定的形式，延长了用户整个智能设 备体系的使用周期。在健康消费升级的趋势下，兼具便携性与功能性的智能健康设备，成为越来越多人 的"刚需品"。 "国补"扩围进一步激活健康消费市场。最新公布的2026年"国补"政策，将数码产品购新补贴拓 ...

科网股走势分化，哔哩哔哩、比亚迪股份涨超1%，百度集团跌超1%。 1月27日，香港恒生指数开盘涨0.36%，恒生科技指数涨0.16%。 | 代码 | 名称 | 现价 涨跌 | 涨跌幅 | | --- | --- | --- | --- | | મંટી | 恒生指数 | 26863.15c 97.63 0.36% | | | HSTECH | 恒生科技 | 5734.90c 8.91 0.16% | | | HSBIO | 恒生生物科技 | 15672.09c 40.25 0.26% | | | HSCEI | 恒生中国企业指数 | 9173.20c 25.99 0.28% | | | HSCI | 恒生综合指数 | 4136.29c 14.58 0.35% | | 半导体板块走强，天数智芯涨超4%，美佳音控股涨超2%，英诺赛科涨超1%。 | 代码 | 名称 | 现价 | 涨跌幅 | | --- | --- | --- | --- | | 9903 | 天数智芯 | 196.000 | 4.14% | | 0522 | ASMPT | 105.200 | 2.33% | | 6939 | 美佳音控股 | 1. ...